Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald ...

Current health news covers major investments by Merck Animal Health and Gilead Sciences in the U.S., regulatory decisions ...

US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...

Drug companies are expected to challenge any such executive order ... purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...